{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:20:39Z","timestamp":1714659639042},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1534,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2036.2011.04736.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T09:38:42Z","timestamp":1308562722000},"page":"487-493","source":"Crossref","is-referenced-by-count":4,"title":["Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors"],"prefix":"10.1111","volume":"34","author":[{"given":"P.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Monyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Illueca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1572-0241.2008.02089.x","article-title":"Racial and geographic issues in gastroesophageal reflux disease","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1053\/j.gastro.2004.03.077","article-title":"Gastroesophageal reflux among different racial groups in the United States","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00042737-199907000-00010","article-title":"Ethnic differences in gastro-oesophageal reflux disease","volume":"11","author":"Neumann","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1046\/j.1365-2036.2002.01351.x","article-title":"Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease","volume":"16","author":"Spechler","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.265.10.1287","article-title":"Rising incidence of adenocarcinoma of the esophagus and gastric cardia","volume":"265","author":"Blot","year":"1991","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.50.3.368","article-title":"Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA","volume":"50","author":"El-Serag","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","article-title":"Changing patterns in the incidence of esophageal and gastric carcinoma in the United States","volume":"83","author":"Devesa","year":"1998","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","article-title":"Esomeprazole (40\u2003mg) compared with lansoprazole (30\u2003mg) in the treatment of erosive esophagitis","volume":"97","author":"Castell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2005.02339.x","article-title":"Efficacy of esomeprazole 40\u2003mg vs. lansoprazole 30\u2003mg for healing moderate to severe erosive oesophagitis","volume":"21","author":"Fennerty","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10620-005-9062-4","article-title":"A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40\u2003mg) and omeprazole (20\u2003mg) for the treatment of erosive esophagitis","volume":"51","author":"Schmitt","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","article-title":"American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","article-title":"Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/gut.52.8.1085","article-title":"Genetic influences in gastro-oesophageal reflux disease: a twin study","volume":"52","author":"Mohammed","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2133\/dmpk.20.153","article-title":"Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies","volume":"20","author":"Furuta","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1067\/mcp.2001.113959","article-title":"Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin","volume":"69","author":"Furuta","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1440-1746.2002.02790.x","article-title":"Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype","volume":"17","author":"Inaba","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1440-1746.2006.04419.x","article-title":"Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis","volume":"22","author":"Kawamura","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2133\/dmpk.18.48","article-title":"Bioinformatics research on inter-racial difference in drug metabolism. I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19","volume":"18","author":"Shimizu","year":"2003","journal-title":"Drug Metab Pharmacokin"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gut.50.4.451","article-title":"Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants","volume":"50","author":"Fitzgerald","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6963-9-24","article-title":"Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study","volume":"9","author":"Trinacty","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2337\/diacare.25.6.1015","article-title":"The association between diabetes metabolic control and drug adherence in an indigent population","volume":"25","author":"Schectman","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2036.2011.04736.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1164\/rccm.200808-1233OC","article-title":"Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma","volume":"178","author":"Wells","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04736.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04736.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T17:19:41Z","timestamp":1613150381000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1365-2036.2011.04736.x"}},"subtitle":["Race affects healing of erosive oesophagitis"],"short-title":[],"issued":{"date-parts":[[2011,6,20]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04736.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,20]]}}}